nivolumab,Ipilumumab,GRT-C903,GRT-R904
gritstone bio,bms
['solid tumor', '$grts']
$grts presents positive initial phase 2 data in late-line solid tumor patients treated with kras-directed immunotherapy (slate) at #esmo22 
Investor/trader focused primarily in the biopharma sector. 
Tweets are not investment advice and are not recommendations of any kind.